vs
Side-by-side financial comparison of Custom Truck One Source, Inc. (CTOS) and Bio-Techne (TECH). Click either name above to swap in a different company.
Custom Truck One Source, Inc. is the larger business by last-quarter revenue ($422.2M vs $295.9M, roughly 1.4× Bio-Techne). Bio-Techne runs the higher net margin — 12.8% vs -4.2%, a 17.1% gap on every dollar of revenue. On growth, Bio-Techne posted the faster year-over-year revenue change (-6.4% vs -8.5%). Over the past eight quarters, Custom Truck One Source, Inc.'s revenue compounded faster (14.8% CAGR vs 4.2%).
Custom Truck One Source, Inc. is a leading provider of specialized heavy truck and equipment solutions in North America. It offers custom vehicle manufacturing, equipment sales and rentals, aftermarket parts, and maintenance services, serving core infrastructure, utility, construction, and energy industry segments.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
CTOS vs TECH — Head-to-Head
Income Statement — Q1 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $422.2M | $295.9M |
| Net Profit | $-17.8M | $38.0M |
| Gross Margin | 20.3% | 64.6% |
| Operating Margin | 2.9% | 18.4% |
| Net Margin | -4.2% | 12.8% |
| Revenue YoY | -8.5% | -6.4% |
| Net Profit YoY | -333.7% | 68.3% |
| EPS (diluted) | $-0.08 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $422.2M | — | ||
| Q4 25 | $387.3M | $295.9M | ||
| Q3 25 | $359.9M | — | ||
| Q2 25 | $392.2M | $317.0M | ||
| Q1 25 | $307.1M | $316.2M | ||
| Q4 24 | $398.3M | $297.0M | ||
| Q3 24 | $337.5M | $289.5M | ||
| Q2 24 | $320.6M | $306.1M |
| Q1 26 | $-17.8M | — | ||
| Q4 25 | $20.9M | $38.0M | ||
| Q3 25 | $-5.8M | — | ||
| Q2 25 | $-28.4M | $-17.7M | ||
| Q1 25 | $-17.8M | $22.6M | ||
| Q4 24 | $27.6M | $34.9M | ||
| Q3 24 | $-17.4M | $33.6M | ||
| Q2 24 | $-24.5M | $40.6M |
| Q1 26 | 20.3% | — | ||
| Q4 25 | 31.8% | 64.6% | ||
| Q3 25 | 28.0% | — | ||
| Q2 25 | 26.1% | 62.7% | ||
| Q1 25 | 27.9% | 67.9% | ||
| Q4 24 | 29.7% | 65.3% | ||
| Q3 24 | 27.2% | 63.2% | ||
| Q2 24 | 27.8% | 66.4% |
| Q1 26 | 2.9% | — | ||
| Q4 25 | 13.4% | 18.4% | ||
| Q3 25 | 9.1% | — | ||
| Q2 25 | 7.1% | -7.5% | ||
| Q1 25 | 4.0% | 12.2% | ||
| Q4 24 | 16.9% | 16.0% | ||
| Q3 24 | 6.8% | 13.8% | ||
| Q2 24 | 5.5% | 15.0% |
| Q1 26 | -4.2% | — | ||
| Q4 25 | 5.4% | 12.8% | ||
| Q3 25 | -1.6% | — | ||
| Q2 25 | -7.2% | -5.6% | ||
| Q1 25 | -5.8% | 7.1% | ||
| Q4 24 | 6.9% | 11.7% | ||
| Q3 24 | -5.2% | 11.6% | ||
| Q2 24 | -7.6% | 13.3% |
| Q1 26 | $-0.08 | — | ||
| Q4 25 | $0.10 | $0.24 | ||
| Q3 25 | $-0.03 | — | ||
| Q2 25 | $-0.13 | $-0.11 | ||
| Q1 25 | $-0.08 | $0.14 | ||
| Q4 24 | $0.11 | $0.22 | ||
| Q3 24 | $-0.07 | $0.21 | ||
| Q2 24 | $-0.10 | $0.26 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $6.3M | $172.9M |
| Total DebtLower is stronger | $25.9M | $260.0M |
| Stockholders' EquityBook value | $809.1M | $2.0B |
| Total Assets | $3.4B | $2.5B |
| Debt / EquityLower = less leverage | 0.03× | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $6.3M | — | ||
| Q4 25 | $6.3M | $172.9M | ||
| Q3 25 | $13.1M | — | ||
| Q2 25 | $5.3M | $162.2M | ||
| Q1 25 | $5.4M | $140.7M | ||
| Q4 24 | $3.8M | $177.5M | ||
| Q3 24 | $8.4M | $187.5M | ||
| Q2 24 | $8.1M | $152.9M |
| Q1 26 | $25.9M | — | ||
| Q4 25 | $1.6B | $260.0M | ||
| Q3 25 | $1.6B | — | ||
| Q2 25 | $1.6B | $346.0M | ||
| Q1 25 | $1.6B | $330.0M | ||
| Q4 24 | $1.5B | $300.0M | ||
| Q3 24 | $1.6B | $300.0M | ||
| Q2 24 | $1.5B | $319.0M |
| Q1 26 | $809.1M | — | ||
| Q4 25 | $809.1M | $2.0B | ||
| Q3 25 | $784.7M | — | ||
| Q2 25 | $790.1M | $1.9B | ||
| Q1 25 | $813.4M | $2.0B | ||
| Q4 24 | $861.3M | $2.1B | ||
| Q3 24 | $837.5M | $2.1B | ||
| Q2 24 | $856.7M | $2.1B |
| Q1 26 | $3.4B | — | ||
| Q4 25 | $3.4B | $2.5B | ||
| Q3 25 | $3.5B | — | ||
| Q2 25 | $3.6B | $2.6B | ||
| Q1 25 | $3.5B | $2.6B | ||
| Q4 24 | $3.5B | $2.7B | ||
| Q3 24 | $3.6B | $2.7B | ||
| Q2 24 | $3.5B | $2.7B |
| Q1 26 | 0.03× | — | ||
| Q4 25 | 2.03× | 0.13× | ||
| Q3 25 | 2.10× | — | ||
| Q2 25 | 2.04× | 0.18× | ||
| Q1 25 | 1.97× | 0.16× | ||
| Q4 24 | 1.77× | 0.14× | ||
| Q3 24 | 1.87× | 0.14× | ||
| Q2 24 | 1.79× | 0.15× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTOS
| Equipment sales | $273.9M | 65% |
| Rental revenue | $116.3M | 28% |
| Parts sales and services | $32.1M | 8% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
